155 13F filers hold it · −14 against the quarter before · shares held +19.6%
Holdings of 06/30
Health care sectorNasdaq
155 13F filers hold it · −14 against the quarter before · shares held +19.6%
Ra Capital Management holds 0% · −9.9pp on the report before
$54.4K of planned sales filed in 30 days · under 0.1% of the units outstanding
13F filers: 155 · −14 since the quarter before · 06/30 holdings
Famous funds that held Fulcrum Therapeutics in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsFulcrum Therapeutics FULC · 06/30 holdings | $100K | No quarter before |
| Mirae Asset Global InvestmentsFulcrum Therapeutics FULC · 06/30 holdings | $10.9K | Trimmed −14.2% |
| Holder | ||
|---|---|---|
| Ra Capital Management08/14 | 0%0 sh | −9.9pp |
| Nantahala Capital Management08/14 | 8.22%5,475,040 sh | +3.6pp |
| Montanova Capital08/14 | 5.5%3,680,921 sh | −3.9pp |
| TCG Crossover GP II08/14 | 0%0 sh | −7.9pp |
| Bank of America08/03 | 6.7%4,468,123 sh | First report |
| BlackRock07/28 | 7.2%4,802,880 sh | +1.2pp |
| BlackRock Portfolio Management07/17 | 6%4,021,379 sh | First report |
| Tang Capital Management07/15 | 10.4%6,913,329 sh | +2.2pp |
| EcoR1 Capital06/25 | 9%6,000,000 sh | +0.0pp |
| EcoR1 Capital06/25 | 9%6,000,000 sh | First report |
| Tang Capital Management06/10 | 8.2%5,451,800 sh | First report |
| Ra Capital Management02/17 | 9.9%6,649,973 sh | −1.3pp |
| Adage Capital Management25/11/13 | 4.5%2,432,000 sh | −4.0pp |
| BlackRock25/10/17 | 6%3,270,322 sh | −1.5pp |
| Adage Capital Management25/08/12 | 8.5%4,589,000 sh | +2.9pp |
| Suvretta Capital Management25/05/02 | 9.4%5,067,394 sh | +3.1pp |
| Adage Capital Management25/02/12 | 5.56%3,000,000 sh | First report |
| Suvretta Capital Management25/01/06 | 6.3%3,404,612 sh | First report |